Trust Asset Management Has Boosted Buckeye Partners LP (BPL) Position; PTC Therapeutics Has 0.98 Sentiment

March 21, 2018 - By Darrin Black

Trust Asset Management Llc increased Buckeye Partners Lp (BPL) stake by 15.97% reported in 2017Q3 SEC filing. Trust Asset Management Llc acquired 33,442 shares as Buckeye Partners Lp (BPL)’s stock declined 5.01%. The Trust Asset Management Llc holds 242,822 shares with $13.84 million value, up from 209,380 last quarter. Buckeye Partners Lp now has $5.85 billion valuation. The stock decreased 0.92% or $0.37 during the last trading session, reaching $39.84. About 137,285 shares traded. Buckeye Partners, L.P. (NYSE:BPL) has declined 5.99% since March 21, 2017 and is downtrending. It has underperformed by 22.69% the S&P500.

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company has market cap of $1.35 billion. The companyÂ’s lead product is Translarna , for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients; and which is in phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. It currently has negative earnings. It also develops Translarna, which is in Phase II clinical trials for the treatment of mucopolysaccharidosis type I caused by nonsense mutation, nonsense mutation aniridia, and nonsense mutation Dravet syndrome/CDKL5; and RG7916 that is in Phase I clinical trials to treat spinal muscular atrophy.

Since March 9, 2018, it had 0 buys, and 1 insider sale for $483,707 activity. The insider Sauger Joseph sold 11,013 shares worth $483,707.

Among 17 analysts covering Buckeye Partners (NYSE:BPL), 6 have Buy rating, 1 Sell and 10 Hold. Therefore 35% are positive. Buckeye Partners had 53 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Monday, February 12 by Barclays Capital. The stock of Buckeye Partners, L.P. (NYSE:BPL) has “Hold” rating given on Monday, February 12 by Guggenheim. The stock of Buckeye Partners, L.P. (NYSE:BPL) has “Equal-Weight” rating given on Monday, August 7 by Barclays Capital. The stock of Buckeye Partners, L.P. (NYSE:BPL) earned “Neutral” rating by Goldman Sachs on Thursday, August 25. The company was maintained on Tuesday, March 6 by Bank of America. On Friday, November 3 the stock rating was maintained by SunTrust with “Hold”. The rating was maintained by RBC Capital Markets on Monday, August 7 with “Hold”. The firm has “Buy” rating by Stifel Nicolaus given on Monday, November 6. UBS maintained the shares of BPL in report on Friday, March 2 with “Buy” rating. Credit Suisse initiated Buckeye Partners, L.P. (NYSE:BPL) on Wednesday, October 12 with “Neutral” rating.

Investors sentiment decreased to 0.57 in 2017 Q3. Its down 0.43, from 1 in 2017Q2. It turned negative, as 39 investors sold BPL shares while 93 reduced holdings. 29 funds opened positions while 103 raised stakes. 96.89 million shares or 5.45% more from 91.89 million shares in 2017Q2 were reported. Utd Capital Advisers Ltd holds 0.07% of its portfolio in Buckeye Partners, L.P. (NYSE:BPL) for 152,786 shares. Manufacturers Life The holds 0% or 4,365 shares in its portfolio. Sequoia Finance Ltd Liability Company stated it has 4,588 shares. Ipswich Invest Mngmt Co Inc owns 4,582 shares for 0.12% of their portfolio. Rafferty Asset Mgmt Limited Liability reported 0.06% stake. Shanda Asset Holding Ltd reported 0.35% of its portfolio in Buckeye Partners, L.P. (NYSE:BPL). Salient Ltd Co owns 17,366 shares or 0.02% of their US portfolio. Ptnrs Group Hldg Ag owns 12,500 shares or 0.08% of their US portfolio. Huntington Bankshares owns 33,965 shares. Geode Cap Management Lc, Massachusetts-based fund reported 7,305 shares. 1,275 are owned by Focused Wealth Mngmt. Bank Of Ny Mellon has invested 0% in Buckeye Partners, L.P. (NYSE:BPL). Klingenstein Fields & Ltd Limited Liability Company reported 0.01% stake. Starr invested in 0.67% or 130,000 shares. Samson Capital Management Limited Company has 2.42% invested in Buckeye Partners, L.P. (NYSE:BPL).

Analysts await PTC Therapeutics, Inc. (NASDAQ:PTCT) to report earnings on May, 14. They expect $-0.35 EPS, up 58.82% or $0.50 from last year’s $-0.85 per share. After $0.03 actual EPS reported by PTC Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -1,266.67% negative EPS growth.

Since January 1, 0001, it had 0 buys, and 4 insider sales for $61,523 activity.

The stock increased 0.34% or $0.11 during the last trading session, reaching $32.39. About 97,313 shares traded. PTC Therapeutics, Inc. (PTCT) has risen 104.51% since March 21, 2017 and is uptrending. It has outperformed by 87.81% the S&P500.

Consonance Capital Management Lp holds 8.73% of its portfolio in PTC Therapeutics, Inc. for 3.95 million shares. Great Point Partners Llc owns 1.10 million shares or 4.28% of their US portfolio. Moreover, Spark Investment Management Llc has 0.77% invested in the company for 717,000 shares. The Massachusetts-based Bogle Investment Management L P De has invested 0.76% in the stock. Sectoral Asset Management Inc, a Quebec – Canada-based fund reported 170,535 shares.

Ratings analysis reveals 67% of PTC Therapeutics’s analysts are positive. Out of 3 Wall Street analysts rating PTC Therapeutics, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. PTCT was included in 3 notes of analysts from November 11, 2016. Citigroup upgraded the shares of PTCT in report on Friday, November 11 to “Buy” rating. The stock of PTC Therapeutics, Inc. (NASDAQ:PTCT) has “Sector Perform” rating given on Friday, November 11 by RBC Capital Markets. Credit Suisse upgraded the stock to “Outperform” rating in Monday, November 14 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News